参考文献/References:
1 Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [J]. Lancet, 2012, 380(9859): 2163-2196.
2 Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study [J]. Ann Rheum Dis, 2014, 73(7): 1323-1330.
3 Long DL, Ulici V, Chubinskaya S, et al. Heparin-binding epidermal growth factor-1ike growth factor(HB-EGF)is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities [J]. Osteoarthritis Cartilage, 2015, 23(9): 1523-1531.
4 Jia H, Ma X, Tong W, et al. EGFR signaling is critical for maintaining the superficial layer of articularcartilage and preventing osteoarthritis initiation [J]. Proc Natl Acad Sci U S A, 2016, 113(50): 14360-14365.
5 Mobasheri A, Bondy CA, Moley, et al. Facilitative glucose transporters in articular chondrocytes. Expression, distribution and functional regulation of GLUT isoforms by hypoxia, hypoxia mimetics, growth factors and pro-inflammatory cytokines[J]. Adv Anat Embryol Cell Biol,2008,200:1p following vi, 1-84.
6 Buckwalter JA, Mankin HJ, Grodzinsky AJ. Articular cartilage and osteoarthritis[J].Instr Course Lect, 2005, 54:465-480.
7 Felson DT, Neogi T.Osteoarthritis: is it a disease of cartilage or of bone?[J]. Arthritis Rheum, 2004, 50(2):341-344.
8 Schneider MR, Sibilia M, Erben RG. The EGFR network in bone biology and pathology [J]. Trends EndocrinolMetab, 2009, 20(10): 517-524.
9 Schneider MR, Wolf E. The epidermal growth factor receptor ligands at a glance [J]. J Cell Physiol, 2009, 218(3): 460-466.
10 AppletonCT, UsmaniSE, MortJS, et al. Rho/ROCK and MEK/ERK activation by transforminggrowth factor-a induces articular cartilage degradation[J]. Lab Invest, 2010,90(1): 20-30.
11 袁功武, 兰生辉, 刘曦明. 表皮生长因子受体信号通路对骨折愈合的生物学作用 [J]. 中国矫形外科杂志, 2018, 26(4): 328-332.
12 袁功武, 兰生辉, 曾文波, 等. 吉非替尼对骨折愈合中I,II 及X 型胶原基因表达的影响 [J]. 中国矫形外科杂志, 2018, 26(10): 939-944.
13 Gschwind A, Fischer OM, Ullrich A. The discovery of receptor tyrosine kinases: targets for cancer therapy [J]. Nat Rev Cancer, 2004, 4(5): 361-370.
14 Zhang X, Zhu J, Liu F, et al. Reduced EGFR signaling enhances cartilage destruction in a mouse osteoarthritis model [J]. Bone Res, 2014,5(2): 14015.
15 Pest MA, Russell BA, Zhang YW, et al. Disturbed cartilage and joint homeostasis resulting from a loss of Mitogen-Inducible gene 6 in a mouse model of joint dysfunction [J]. Arthritis Rheumatol, 2014, 66(10): 2816-2827.
16 Shepard JB, Jeong JW, Maihle NJ, et al. Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo [J]. Arthritis Res Ther, 2013, 15(3): R60.
17 Staal B, Williams BO, Beier F, et al. Cartilage-specific deletion of Mig-6 results in osteoarthritis-like disorder with excessive articular chondrocyte proliferation [J]. Proc Natl Acad Sci U S A, 2014, 111(7): 2590-2595.
18 Roskoski R Jr. ERK1/2 MAP kinases: structure, function, and regulation [J]. Pharmacol Res, 2012, 66(2): 105-143.
19 He P, Shen N, Gao G, et al. Periodic mechanical stress activates PKC delta-Dependent EGFR mitogenic signals in rat chondrocytes via PI3K-Akt and ERK1/2 [J]. Cell Physiol Biochem, 2016, 39(4): 1281-1294.
20 Naik B, Kumar M, Khanna AK, et al. Clinico-histopathological study of varicose vein and role of matrix metalloproteinases-1,matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinase-1 in varicose vein formation [J]. Indian J Pathol Microbiol, 2016, 59(1): 25-30.
21 Konstantinos C Tsolis, Ekaterini S Bei, Ioanna Papathanasiou,et al. Comparative proteomic analysis of hypertrophicchondrocytes in osteoarthritis[J].Clin Proteomics,2015,12(1):12.
22 Gehris AL, Stringa E, Spina J, et al. The region encoded by the alternatively splicedexon IIIA in mesenchymal fibronectin appears essential forchondrogenesis at the level of cellular condensation[J]. Dev Biol, 1997,190(2): 191-205.
23 Takeda H, Inoue H, Kutsuna T,et al. Activation of epidermal growth factor receptor gene is involvedin transforming growth factor-?mediated fibronectinexpression in a chondrocyte progenitor cell line[J]. Int J Mol Med,2010,25(4): 593-600.
24 刘艳, 尹若峰, 侯睿智. BMP-2诱导软骨细胞凋亡及增殖的研究 [J]. 中华骨与关节外科杂志, 2016, 9(03): 251-254.
25 Goggs R, Carter SD, Schulze-Tanzil G, et al. Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis [J]. Vet J, 2003, 166(2): 140-158.
26 So T, Croft M. Regulation of PI-3-kinase and Akt signaling in T lymphocytes and other cells by TNFR family molecules [J]. Front Immunol, 2013, 4: 139.
27 ShengZG, HuangW, LiuYX, et al.Ofloxacin induces apoptosis via β1 integrin-EGFR-Rac1-Nox2 pathway inmicroencapsulated chondrocytes[J]. Toxicol Appl Pharmacol, 2013,267(1):74-87.
28 Goldring MB, Goldring SR. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis[J].Ann N Y Acad Sci, 2010. 1192: 230-237.
29 Piel MJ, Kroin JS, Im HJ. Assessment of knee joint pain in experimental rodentmodels of osteoarthritis[J]. Methods Mol Biol, 2015,1226:175-181.
30 Henry SP, Jang CW, Deng JM, et al. Generation of aggrecan-CreERT2 knockin mice for inducibleCre activity in adult cartilage [J]. Genesis, 2009, 47(12): 805-814.
31 Zhang X, Zhu J, Liu F, et al. Reduced EGFR signaling enhances cartilage destruction in a mouse osteoarthritis model [J]. Bone Res, 2014,5(2): 14015.][Henry SP, Jang CW, Deng JM, et al. Generation of aggrecan-CreERT2 knockin mice for inducibleCre activity in adult cartilage [J]. Genesis, 2009, 47(12): 805-814.
32 Bonnevie ED, Galesso D, Secchieri C, et al. Elastoviscous transitions of articular cartilage reveal a mechanism of synergy between lubricin and hyaluronic acid [J]. PLoS One, 2015, 10(11): e0143415.
33 Das S, Banquy X, Zappone B, et al. Synergistic interactions between grafted hyaluronic acid and lubricin provide enhanced wear protection and lubrication [J]. Biomacromolecules, 2013, 14(5): 1669-1677.
34 Lim H, Kim HP. Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways [J]. Arch Pharm Res, 2011, 34(1): 109-117.
35 Long DL, Loeser RF. p38gamma mitogen-activated protein kinase suppresses chondrocyte production of MMP-13 in response to catabolic stimulation [J]. Osteoarthritis Cartilage, 2010, 18(9): 1203-1210.